AU
UK
CA
NZ
IND
US
Telix Pharmaceuticals (ASX/NASDAQ: TLX) has appointed Anne Whitaker as a Non-Executive Director, effective April 7, 2025. Whitaker's appointment brings a wealth of knowledge and experience to the company, stemming from over three decades in the pharmaceutical, biotech, and specialty pharmaceutical sectors.
Index Update
Phase III ALIGN Study:Approval is based on interim data from a clinical trial showing proteinuria reduction at 36 weeks. Full results, including kidney function impact, are expected in 2026.
Revenue Decline:Sales fell 5% to $2.372 billion, but still topped forecasts of $2.33 billion.
Stock Drops:J&J shares fell 7.6%, closing at $153.25, marking a sharp reversal from its recent breakout.
Global Decline:Sales dropped49% in China (Feb), 76.3% in Germany (Feb), and 2% in the U.S. (Jan-Feb).
High Demand Expected:The originalSwitch sold nearly 151 million units, making it Nintendo’sbest-selling home consoleever.
Index Update
Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI), a California-based company focused on intelligent electric mobility, has unveiled the front fascia design of its upcoming Faraday X (FX) model. This model is expected to roll off the production line by the end of 2025, marking …
Please wait processing your request...